SCHEMBL3640313

SCHEMBL3640313

CCN(C(=O)O)C(=S)Nc1ccc(Oc2ccc(C)c(NC(=O)OC(C)(C)C)c2)cn1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.36
ALDH1A1 P00352 3/20 0.36
MET P08581 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
TP53 P04637 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
BRD9 Q9H8M2 1/20 0.33
P2RX3 P56373 1/20 0.33
MAP4K1 Q92918 1/20 0.33
BRAF P15056 1/20 0.33
KDR P35968 1/20 0.33
MAPKAPK2 P49137 1/20 0.33
FGFR4 P22455 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3642174 0.90 BRAF (0.40) MAPTMETSMN1; SMN2BRAFKDR
SCHEMBL3637237 0.90 MAPK14 (0.36) MAPTALDH1A1METP2RX3BRAF
SCHEMBL3513086 0.86 CDK8 (0.41) ALDH1A1SMN1; SMN2TP53KDR
SCHEMBL4282370 0.83 MAPT (0.43) MAPTALDH1A1METHPGDNPSR1
SCHEMBL13636110 0.82 MAPT (0.43) MAPTALDH1A1METKDR
SCHEMBL3812516 0.81 KDR (0.49) BRAFKDR
SCHEMBL13636108 0.75 CDK8 (0.52)
SCHEMBL1259491 0.75 TSHR (0.44) MAPTALDH1A1METSMN1; SMN2TP53
SCHEMBL4282325 0.74 NPC1 (0.39) MAPTALDH1A1METHPGDNPSR1
SCHEMBL4280655 0.74 BRAF (0.43) MAPTMETBRAFKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2162445-A1 HETEROBICYCLIC COMPOUNDS AS KINASE INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2010-03-17 EP disclosed
WO-2008150015-A1 HETEROBICYCLIC COMPOUNDS AS KINASE INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-11 WO disclosed